109 related articles for article (PubMed ID: 9419767)
1. Cathepsin D activity in human ovarian tissues and ovarian carcinoma.
Hradek DI; Kessel B; Husseinzadeh N; Moulton BC
J Soc Gynecol Investig; 1994; 1(2):173-7. PubMed ID: 9419767
[TBL] [Abstract][Full Text] [Related]
2. Cathepsin D assay in ovarian cancer: correlation with pathological features and receptors for oestrogen, progesterone and epidermal growth factor.
Scambia G; Benedetti P; Ferrandina G; Battaglia F; Baiocchi G; Mancuso S
Br J Cancer; 1991 Jul; 64(1):182-4. PubMed ID: 1854619
[TBL] [Abstract][Full Text] [Related]
3. Ki-67 staining in benign, borderline, malignant primary and metastatic ovarian tumors: correlation with steroid receptors, epidermal-growth-factor receptor and cathepsin D.
Henzen-Logmans SC; Fieret EJ; Berns EM; van der Burg ME; Klijn JG; Foekens JA
Int J Cancer; 1994 May; 57(4):468-72. PubMed ID: 8181851
[TBL] [Abstract][Full Text] [Related]
4. Significance of estrogen receptors and cathepsin D tissue detection in gastric adenocarcinoma.
Theodoropoulos GE; Lazaris AC; Panoussopoulos D; Davaris P; Golematis BC
J Surg Oncol; 1995 Mar; 58(3):176-83. PubMed ID: 7898114
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological significance of cathepsin D expression in gastric adenocarcinoma.
Ikeguchi M; Fukuda K; Oka S; Yamaguchi K; Hisamitsu K; Tsujitani S; Sakatani T; Ueda T; Kaibara N
Oncology; 2001; 61(1):71-8. PubMed ID: 11474252
[TBL] [Abstract][Full Text] [Related]
6. [Cathepsin D activity in human ovarian carcinoma].
Reich W; Wagner F; Hofmann KD; Marzotko F; Schmeisser G
Zentralbl Gynakol; 1984; 106(3):196-200. PubMed ID: 6702349
[TBL] [Abstract][Full Text] [Related]
7. Expression of cathepsin-D, CA125 and epidermal growth factor receptor in imprint smears of ovarian carcinoma.
Athanassiadou P; Sakellariou V; Michalas S; Petrakakou E; Zerva C; Athanassiades P; Aravantinos D
Gynecol Obstet Invest; 1997; 43(2):125-30. PubMed ID: 9067721
[TBL] [Abstract][Full Text] [Related]
8. Modulation of proliferation and chemosensitivity by procathepsin D and its peptides in ovarian cancer.
Bazzett LB; Watkins CS; Gercel-Taylor C; Taylor DD
Gynecol Oncol; 1999 Aug; 74(2):181-7. PubMed ID: 10419729
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of cathepsin D as prognostic predictor in breast cancer.
Barbi GP; Margallo E; Margiocco M; Paganuzzi M; Marroni P; Costanzi B; Gatteschi B; Tanara G; Spina B; Nicolò G
Oncology; 1994; 51(4):329-33. PubMed ID: 8208515
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical evaluation of cathepsin D expression in colorectal cancer.
Mayer A; Fritz E; Fortelny R; Kofler K; Ludwig H
Cancer Invest; 1997; 15(2):106-10. PubMed ID: 9095205
[TBL] [Abstract][Full Text] [Related]
11. Comparison of cathepsin D determinations in human carcinomas by enzyme immunoassay and immunoradiometric assay.
Shaheen RM; Miseljic S; Doering DL; Wittliff JL
J Clin Lab Anal; 1995; 9(6):351-8. PubMed ID: 8587002
[TBL] [Abstract][Full Text] [Related]
12. Relation between cathepsin D expression and other prognostic factors in breast carcinomas.
Shaheen RM; Miseljic S; Wiehle RD; Wittliff JL
Clin Chem; 1995 Nov; 41(11):1585-91. PubMed ID: 7586547
[TBL] [Abstract][Full Text] [Related]
13. Receptors for hormones and growth factors and (onco)-gene amplification in human ovarian cancer.
Berns EM; Klijn JG; Henzen-Logmans SC; Rodenburg CJ; van der Burg ME; Foekens JA
Int J Cancer; 1992 Sep; 52(2):218-24. PubMed ID: 1325950
[TBL] [Abstract][Full Text] [Related]
14. Quantitative immunohistochemical determination of cathepsin D levels in prostatic carcinoma biopsies. Correlation with tumor grade, stage, PSA level, and DNA ploidy status.
Ross JS; Nazeer T; Figge HL; Fisher HA; Rifkin MD
Am J Clin Pathol; 1995 Jul; 104(1):36-41. PubMed ID: 7541934
[TBL] [Abstract][Full Text] [Related]
15. Lysosomal protease cathepsin D is a prognostic marker in endometrial cancer.
Lösch A; Kohlberger P; Gitsch G; Kaider A; Breitenecker G; Kainz C
Br J Cancer; 1996 Jun; 73(12):1525-8. PubMed ID: 8664123
[TBL] [Abstract][Full Text] [Related]
16. Cathepsin D in ovarian cancer: prognostic value and correlation with p53 expression and microvessel density.
Lösch A; Schindl M; Kohlberger P; Lahodny J; Breitenecker G; Horvat R; Birner P
Gynecol Oncol; 2004 Feb; 92(2):545-52. PubMed ID: 14766246
[TBL] [Abstract][Full Text] [Related]
17. Cathepsin-D expression in cervical carcinoma and its prognostic significance.
Mitchell KM; Hale RJ; Buckley CH; Fox H; Smith D
Virchows Arch A Pathol Anat Histopathol; 1993; 422(5):357-60. PubMed ID: 8322451
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin D expression levels in nongynecological solid tumors: clinical and therapeutic implications.
Leto G; Tumminello FM; Crescimanno M; Flandina C; Gebbia N
Clin Exp Metastasis; 2004; 21(2):91-106. PubMed ID: 15168727
[TBL] [Abstract][Full Text] [Related]
19. Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients.
Szajda SD; Snarska J; Jankowska A; Roszkowska-Jakimiec W; Puchalski Z; Zwierz K
Hepatogastroenterology; 2008; 55(82-83):388-93. PubMed ID: 18613372
[TBL] [Abstract][Full Text] [Related]
20. CD44 expression in colorectal cancer. An immunohistochemical study including correlation with cathepsin D immunoreactivity and some tumour clinicopathological features.
Zalewski B; Famulski W; Sulkowska M; Sobaniec-Lotowska M; Piotrowski Z; Kisielewski W; Sulkowski S
Folia Histochem Cytobiol; 2001; 39 Suppl 2():152-3. PubMed ID: 11820582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
